Strategic Collaborations Ionica Sciences pursues partnerships with prestigious research institutions and government programs (Cornell University, City College of New York, DARPA) to advance detector technology, presenting sales opportunities for collaborative development, contract research, and co-funded projects.

High Sensitivity Offerings The company targets detection and quantitation at pg/ml levels for biologically relevant molecules, suggesting potential commercial value in ultra-sensitive diagnostics and environmental monitoring devices suited for government agencies, pharma, and defense sectors.

FDA-Ready Pipeline With an aim to bring an FDA-approved assay to market within 3-5 years, there is a clear path for regulatory-focused partnerships, testing services, and contract development of point-of-care diagnostic platforms.

SBIR/Grant Credibility Co-founders' track record of SBIR funding and successful program outcomes builds credibility for clients seeking grant-aligned R&D, co-development agreements, or sponsorships that leverage public funding.

Niche Market Fit Focus on rapid, inexpensive assays for point-of-care use with minimal training indicates opportunities in healthcare clinics, field testing, water safety, and biodefense, where turnkey spectral detection solutions can reduce time to results.